Technology Opportunities & Ventures
While focus is on header menu items,
press the down arrow to open sub-menu.
press the down arrow to open sub-menu.
2018
Inactive
Principal Investigators: Spiros Hiotis, MD, PhD
Saronic Biotechnology, Inc. is a preclinical and clinical-stage drug development company established to bring novel immunotherapeutics to clinical use for patients with liver cancer. Founded in New York City by a dedicated team of physicians and scientists with broad expertise in oncology and immunology, Saronic Biotechnology developed its lead product SBI1997, an immunotherapy for hepatocellular carcinoma (HCC). In addition to its innovative clinical program, Saronic Biotechnology has also created a streamlined research pipeline to develop additional therapeutics for launch into phase I clinical trials.